Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
InSightec
Servier
InSightec
National Institutes of Health Clinical Center (CC)
Novelwise Pharmaceutical Corporation
Tango Therapeutics, Inc.
Case Comprehensive Cancer Center
NaviFUS Corporation
Hoosier Cancer Research Network
Stemline Therapeutics, Inc.
Weill Medical College of Cornell University
University of Texas Southwestern Medical Center
Hoffmann-La Roche